Home | About Us | Current Issue | Ahead of print | Archives | Search | Instructions | Subscription | Feedback | Editorial Board | e-Alerts | Login 
Journal of Indian Association of Pediatric Surgeons
     Journal of Indian Association of Pediatric Surgeons
Official journal of the Indian Association of Pediatric Surgeons         
 Users Online:623 
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Contrast-enhanced CT features of hepatoblastoma: Can we predict histopathology?
Akshay D. Baheti,A. Luana Stanescu,Ning Li,Teresa Chapman
Clinical Imaging.2017;44()33
[DOI]
2Use of a donor iliac vein graft for reconstruction of the inferior vena cava in liver transplantation for hepatoblastoma with caval extension
Amy Hort,Jonathan Karpelowsky,Albert Shun,Gordon Thomas
Pediatric Transplantation.2019;23(4)e13409
[DOI]
3Management of Hepatoblastoma: ICMR Consensus Document
Sandeep Agarwala,Alisha Gupta,Deepak Bansal,Tushar Vora,Maya Prasad,Brijesh Arora,Gauri Kapoor,Girish Chinnaswamy,Venkatraman Radhakrishnan,Siddharth Laskar,Tanvir Kaur,Rupinder Singh Dhaliwal,G. K. Rath,Sameer Bakhshi
The Indian Journal of Pediatrics.2017;84(6)456
[DOI]
4Cultural, geographical and ethical questions when looking to enroll pediatric patients in rare disease clinical trials
Stefan Anzelewicz,Hanna Garnier,Arun Rangaswami,Piotr Czauderna
Expert Opinion on Orphan Drugs.2017;5(8)613
[DOI]
5Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug Therapies
Rishi Raj Rikhi,Kimberlee K. Spady,Ruth I. Hoffman,Michael S. Bateman,Max Bateman,Lisa Easom Howard
Frontiers in Pediatrics.2016;4(8)613
[DOI]
6Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug Therapies
Matteo Carella,Riccardo Masetti,Claudio Antonellini,Beatrice Randi,Andrea Pession
Frontiers in Pediatrics.2019;4(8)479
[DOI]
7Hepatoblastoma: 16-years’ experience from a tertiary cancer centre in India
Avaronnan Manuprasad,Venkatraman Radhakrishnan,Sunil B. J,A.S. Ramakrishnan,T.S. Ganesan,Prasanth Ganesan,Jaikumar Ramamurthy,Manikandan Dhanushkodi,T.G. Sagar
Pediatric Hematology Oncology Journal.2018;3(1)13
[DOI]
8Hepatoblastoma: current understanding, recent advances, and controversies
Piotr Czauderna,Hanna Garnier
F1000Research.2018;7(1)53
[DOI]
9Hepatoblastoma: current understanding, recent advances, and controversies
M. Tezer Kutluk,Erman Atas
F1000Research.2019;7(1)311
[DOI]
10Hepatoblastoma: current understanding, recent advances, and controversies
M. Tezer Kutluk,Erman Atas
F1000Research.2018;7(1)628
[DOI]
11Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong
Anthony P. Y. Liu,Janice J. K. Ip,Alex W. K. Leung,C. W. Luk,C. H. Li,Karin K. H. Ho,Regina Lo,Edwin K. W. Chan,Albert C. Y. Chan,Patrick H. Y. Chung,Alan K. S. Chiang
Pediatric Blood & Cancer.2019;66(1)e27482
[DOI]
12Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong
Carolina Witchmichen Penteado Schmidt
Pediatric Blood & Cancer.2019;66(1)5
[DOI]
13The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database
Beate Haeberle,Arun Rangaswami,Mark Krailo,Piotr Czauderna,Eiso Hiyama,Rudolf Maibach,Dolores Lopez-Terrada,Daniel C. Aronson,Rita Alaggio,Marc Ansari,Marcio H. Malogolowkin,Giorgio Perilongo,Allison F. O'Neill,Angela D. Trobaugh-Lotrario,Kenichiro Watanabe,Irene Schmid,Dietrich Schweinitz,Sarangarajan Ranganathan,Kenichi Yoshimura,Tomoro Hishiki,Yukichi Tanaka,Jin Piao,Yurong Feng,Eugenia Rinaldi,Davide Saraceno,Marisa Derosa,Rebecka L. Meyers
Pediatric Blood & Cancer.2020;67(8)5
[DOI]
14Laparoscopic-assisted extended right hepatectomy for hepatoblastoma in a child (Video)
D. Akhaladze,N. Merkulov,G. Rabaev
Surgical Oncology.2020;34(8)234
[DOI]
15Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
Jose Marin,Candela Cives-Losada,Maitane Asensio,Elisa Lozano,Oscar Briz,Rocio Macias
Cancers.2019;11(3)407
[DOI]
16Outcomes for high-risk hepatoblastoma in a resource-challenged setting
A. Rammohan,M. Rela,G. V. Kumar,J. X. Scott,N. Shanmugam,M. S. Reddy,P. Ramachandran
BJS Open.2020;4(4)630
[DOI]
17Indian Pediatric Oncology Group (InPOG) – Collaborative research in India comes of age
Ramandeep Singh Arora,Sameer Bakhshi
Pediatric Hematology Oncology Journal.2016;1(1)13
[DOI]
18Resection of hepatic tumors with central venous and right atrial extension using cardiopulmonary bypass
Michael J. LaQuaglia,Heung Bae Kim,Francis Fynn-Thompson,Christopher Baird,Khashayar Vakili
Journal of Pediatric Surgery Case Reports.2018;30(1)14
[DOI]
19Metformin attenuates hypoxia-induced resistance to cisplatin in the HepG2 cell line
Hiromasa Fujita,Katsumi Hirose,Mariko Sato,Ichitaro Fujioka,Tamaki Fujita,Masahiko Aoki,Yoshihiro Takai
Oncology Letters.2018;30(1)14
[DOI]
20Central segments liver resection for pediatric tumors
D. G. Akhaladze,D. Y. Kachanov,N. G. Uskova,O. V. Melekhina,N. N. Merkulov,S. R. Talypov,V. V. Schukin,I. V. Zhilkin,G. S. Rabaev,R. A. Moiseenko,N. S. Grachev
Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery.2020;25(1)8
[DOI]
21Liver biopsy for hepatoblastoma: a single institution’s experience
Manna Zheng,Jiahao Li,Chao Hu,Tianbao Tan,Jiliang Yang,Jing Pan,Huiying Wu,Haibo Li,Lianwei Lu,Xiwen Chen,Xiaohong Zhang,Tao Xu,Yan Zou,Tianyou Yang
Pediatric Surgery International.2020;36(8)909
[DOI]
22Diagnosis, histopathologic correlation and management of hepatoblastoma: What the radiologist needs to know
Akshay D. Baheti,Teresa Chapman,Erin Rudzinski,Catherine Michelle Albert,A. Luana Stanescu
Clinical Imaging.2018;52(8)273
[DOI]
23Successful treatment of a metastatic hepatocellular malignant neoplasm, not otherwise specified with chemotherapy and liver transplantation
Michaela S. Seng,Bligh Berry,Jonathan Karpelowsky,Gordon Thomas,Catherine Mews,Michael Stormon,Albert Shun,Catherine Cole
Pediatric Blood & Cancer.2019;66(4)e27603
[DOI]
24Two Cases of Hepatoblastoma in Young Adults
Karel de Bree,Anneke M. Westermann,Heinz-Josef Klümpen,Joanne Verheij,Saffire S.K.S. Phoa,Matthijs Oomen,Thomas M. van Gulik
Journal of Adolescent and Young Adult Oncology.2018;7(3)404
[DOI]
25New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
Katarzyna B. Hooks,Jérôme Audoux,Helena Fazli,Sarah Lesjean,Tony Ernault,Nathalie Dugot-Senant,Thierry Leste-Lasserre,Martin Hagedorn,Benoit Rousseau,Coralie Danet,Sophie Branchereau,Laurence Brugières,Sophie Taque,Catherine Guettier,Monique Fabre,Anne Rullier,Marie-Annick Buendia,Thérèse Commes,Christophe F. Grosset,Anne-Aurélie Raymond
Hepatology.2018;68(1)89
[DOI]
26Malignant tumors of the liver in children
Daniel C. Aronson,Rebecka L. Meyers
Seminars in Pediatric Surgery.2016;25(5)265
[DOI]
27Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
Laura L. Stafman,Smitha Mruthyunjayappa,Alicia M. Waters,Evan F. Garner,Jamie M. Aye,Jerry E. Stewart,Karina J. Yoon,Kimberly Whelan,Elizabeth Mroczek-Musulman,Elizabeth A. Beierle
Oncotarget.2018;9(32)22665
[DOI]
28A single-center retrospective study of pediatric hepatoblastoma
Yi Zhang,Weiling Zhang,Suoqin Tang,Liping Chen,You Yi,Pinwei Zhang,Aiping Liu,Tian Zhi,Dongsheng Huang
Oncology Letters.2016;12(5)3919
[DOI]
29Surgical treatment of childhood hepatoblastoma in the Netherlands (1990–2013)
Linde A. D. Busweiler,Marc H. W. A. Wijnen,Jim C. H. Wilde,Egbert Sieders,Sheila E. J. Terwisscha van Scheltinga,L. W. Ernest van Heurn,Joseph Ziros,Roel Bakx,Hugo. A. Heij
Pediatric Surgery International.2017;33(1)23
[DOI]
30Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Juan Carrillo-Reixach,Laura Torrens,Marina Simon-Coma,Laura Royo,Montserrat Domingo-Sàbat,Jordi Abril-Fornaguera,Nicholas Akers,Margarita Sala,Sonia Ragull,Magdalena Arnal,Núria Villalmanzo,Stefano Cairo,Alberto Villanueva,Roland Kappler,Marta Garrido,Laura Guerra,Constantino Sábado,Gabriela Guillén,Mar Mallo,David Piñeyro,María Vázquez-Vitali,Olga Kuchuk,María Elena Mateos,Gema Ramírez,Manuel López Santamaría,Yasmina Mozo,Aroa Soriano,Michael Grotzer,Sophie Branchereau,Nagore García de Andoin,Blanca López-Ibor,Ricardo López-Almaraz,José Antonio Salinas,Bárbara Torres,Francisco Hernández,José Javier Uriz,Monique Fabre,Julià Blanco,Claudia Paris,Viera Bajciová,Geneviève Laureys,Helena Masnou,Ariadna Clos,Cristina Belendez,Catherine Guettier,Lauro Sumoy,Ramón Planas,Mireia Jordà,Lara Nonell,Piotr Czauderna,Bruce Morland,Daniela Sia,Bojan Losic,Marie Annick Buendia,Maria Rosa Sarrias,Josep M. Llovet,Carolina Armengol
Journal of Hepatology.2020;73(2)328
[DOI]
31Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children's Hospital
Michael Kueht,Patrick Thompson,Abbas Rana,Ronald Cotton,Christine O'Mahony,John Goss
Pediatric Transplantation.2016;20(4)515
[DOI]
32Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children's Hospital
A. Pire,C. Chardot
Pediatric Transplantation.2018;20(4)211
[DOI]
33Ovarian tissue cryopreservation in young females through the Oncofertility Consortium's National Physicians Cooperative
Austin G Armstrong,Bruce F Kimler,Brigid M Smith,Teresa K Woodruff,Mary Ellen Pavone,Francesca E Duncan
Future Oncology.2018;14(4)363
[DOI]
34DPEP1 is a direct target of miR-193a-5p and promotes hepatoblastoma progression by PI3K/Akt/mTOR pathway
Xichun Cui,Xin Liu,Qicai Han,Jianming Zhu,Jianhao Li,Zhigang Ren,Liwen Liu,Yanbing Luo,Zhifang Wang,Dandan Zhang,Yingzhong Fan,Da Zhang,Gang Dong
Cell Death & Disease.2019;10(10)363
[DOI]
35Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoproteinin vitroandin vivoinvolving the NFkappaB- and the beta-catenin pathways
Nicola Bortel,Sorin Armeanu-Ebinger,Evi Schmid,Bettina Kirchner,Jan Frank,Alexa Kocher,Christina Schiborr,Steven Warmann,Jörg Fuchs,Verena Ellerkamp
Oncotarget.2015;6(38)40680
[DOI]
36Surgical Resection for Hepatoblastoma—Updated Survival Outcomes
Bhanu Jayanand Sunil,Ravisankar Palaniappan,Balasubramanian Venkitaraman,Rama Ranganathan
Journal of Gastrointestinal Cancer.2018;49(4)493
[DOI]
37Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report
Daniel C. Aronson,Víola B. Weeda,Rudolf Maibach,Piotr Czauderna,Patrizia Dall’Igna,Jean de Ville de Goyet,Sophie Branchereau,Giorgio Perilongo,Penelope Brock,Joszef Zsiros,Michaela Semeraro,Christophe Chardot,Barbara Wildhaber,Bruce Morland,Laurence Brugières
European Journal of Cancer.2019;106(4)126
[DOI]
38Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report
Mhamed Harif,Daniela Cristina Stefan
European Journal of Cancer.2017;106(4)107
[DOI]
39Indications and efficacy of conversion from tacrolimus- to sirolimus-based immunosuppression in pediatric patients who underwent liver transplantation for unresectable hepatoblastoma
Richard J. Hendrickson,Joseph Sujka,Ryan Fischer,Michelle Manalang,James Daniel,Walter S. Andrews
Pediatric Transplantation.2019;23(3)107
[DOI]
  Site Statistics 
  Addresses 
  Search 
  My Preferences 
  Online Submission 

 



Contact us | Sitemap | Advertise | What's New | Copyright and Disclaimer 

 © 2005 - Journal of Indian Association of Pediatric Surgeons | Published by Wolters Kluwer - Medknow 

Online since 1st May '05